Skip to main content
. 2019 Apr 5;16(4):e1002777. doi: 10.1371/journal.pmed.1002777

Fig 1. Trial profile.

Fig 1

CT, computed tomography; ESRD, end-stage renal disease; GFR, glomerular filtration rate; octreotide-LAR, octreotide long-acting release; TKV, total kidney volume.